Dianthus Therapeutics, INC. /De/ (DNTH) SEC Filings — 2025
11 SEC filings for Dianthus Therapeutics, INC. /De/ (DNTH) in 2025.
Filings
- Dianthus's Net Loss Widens 73% Amid Soaring R&D, Cash Reserves Up — 10-Q · Nov 5, 2025
- Dianthus Therapeutics Files 8-K — 8-K · Nov 3, 2025
- Dianthus Therapeutics Files 8-K — 8-K · Oct 16, 2025
- Dianthus Therapeutics Enters Material Definitive Agreement — 8-K · Sep 11, 2025
- Dianthus Therapeutics Files 8-K Report — 8-K · Sep 8, 2025
- Dianthus's Net Loss Widens to $45.2M Amid Rising R&D Costs — 10-Q · Aug 7, 2025
- Dianthus Therapeutics Files 8-K on Officer/Director Changes — 8-K · May 22, 2025
- Dianthus Therapeutics Q1 2025 Update — 10-Q · May 12, 2025
- Dianthus Therapeutics DEF 14A: Executive Compensation Details — DEF 14A · Apr 10, 2025
- Dianthus Therapeutics Files 2024 10-K — 10-K · Mar 11, 2025
- Dianthus Therapeutics Appoints New CMO, Director — 8-K · Mar 5, 2025